ENvue Medical, Inc.
FEED
$0.82
-$0.01-0.89%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 109.29% | -56.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 109.29% | -56.79% | |||
| Cost of Revenue | 3.81% | 27.95% | |||
| Gross Profit | 85.14% | -295.77% | |||
| SG&A Expenses | -1.94% | 46.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.87% | 33.78% | |||
| Operating Income | -1.39% | -62.88% | |||
| Income Before Tax | 71.45% | -2,535.05% | |||
| Income Tax Expenses | 107.88% | -1,297.14% | |||
| Earnings from Continuing Operations | 70.26% | -2,620.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 70.26% | -2,620.00% | |||
| EBIT | -1.39% | -62.88% | |||
| EBITDA | -2.70% | -70.95% | |||
| EPS Basic | 44.40% | -1,261.40% | |||
| Normalized Basic EPS | 40.72% | -401.07% | |||
| EPS Diluted | 44.40% | -1,261.40% | |||
| Normalized Diluted EPS | 40.72% | -401.07% | |||
| Average Basic Shares Outstanding | 198.65% | 28.30% | |||
| Average Diluted Shares Outstanding | 198.65% | 28.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||